Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Do drug firm links sway psychiatry?

Aldhous P.

New Sci. 2006 Apr 29-May 5;190(2549):14. No abstract available.

PMID:
17111513
2.

Medical professionalism--focusing on the real issues.

Ruane TJ.

N Engl J Med. 2000 Sep 7;343(10):739-40. No abstract available.

PMID:
10979775
3.

Financial ties between DSM-IV panel members and the pharmaceutical industry.

Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L.

Psychother Psychosom. 2006;75(3):154-60.

PMID:
16636630
4.

DSM-5: riddled with conflicts of interest.

[No authors listed]

Prescrire Int. 2015 Jan;24(156):4. No abstract available.

PMID:
25729820
5.

Study cites links to firms by psychiatrists.

Carey B.

N Y Times Web. 2006 Apr 20:A23. No abstract available.

PMID:
16649281
6.

Is financial gain to blame for the growing ADHD epidemic?

Lardizabal A.

J Child Adolesc Psychiatr Nurs. 2012 Aug;25(3):164. doi: 10.1111/j.1744-6171.2012.00334.x. Epub 2012 Jul 3. No abstract available.

PMID:
22830515
7.

Confronting the conflict of interest crisis in medical research.

Lemmens T.

Monash Bioeth Rev. 2004 Oct;23(4):19-40.

PMID:
15688510
8.

Pharma payment probe widens its net.

Wadman M.

Nature. 2008 Oct 23;455(7216):1017. doi: 10.1038/4551017a. No abstract available.

PMID:
18948916
9.

Pharma buys a conscience.

Elliott C.

Am Prospect. 2001 Sep 24-Oct 8;12(17):16-20. No abstract available.

PMID:
16184653
10.

Research dishonesty and conflict of interest.

Frizelle F.

N Z Med J. 2002 Dec 13;115(1167):U270. No abstract available.

PMID:
12552259
11.

The role of industry interactions with the American College of Gastroenterology.

ACG Professional Affairs Committee.

Am J Gastroenterol. 2012 Jun;107(6):800-3. doi: 10.1038/ajg.2011.467. No abstract available.

PMID:
22664840
12.

Obesity association clarifies definitions of obesity and links with drug firms.

Rigby N.

BMJ. 2006 Jul 1;333(7557):44. No abstract available.

13.

Profits, pressure, and perception: expensive research collides with medicine.

Hoey J.

J Rheumatol. 2003 Aug;30(8):1661-2. No abstract available.

PMID:
12913915
14.

Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues.

Caulfield T.

Health Law Rev. 2005;13(2-3):114-6. No abstract available.

PMID:
16459424
15.

Unease on industry's role in hypertension debate.

Saul S.

N Y Times Web. 2006 May 20:A1, C9. No abstract available.

PMID:
16752458
16.

Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.

Berger E.

Ann Emerg Med. 2008 Aug;52(2):137-9. No abstract available.

PMID:
18672488
17.

Industry funding and author-industry affiliation in clinical trials in psychiatry.

Montgomery JH.

Am J Psychiatry. 2006 Jun;163(6):1110-1; author reply 1111. No abstract available.

PMID:
16741218
18.

Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretation.

Pollack A, Abelson R.

N Y Times Web. 2006 May 22:C1, C5. No abstract available.

PMID:
16752456
19.

Bias in AJHP supplements.

Kruse MW, Lee JJ.

Am J Health Syst Pharm. 2008 Dec 15;65(24):2328-9; author reply 2329-30; discussion 2330. doi: 10.2146/ajhp080453. No abstract available.

PMID:
19052275
20.

Is academic psychiatry for sale?

Healy D, Thase ME.

Br J Psychiatry. 2003 May;182:388-90. No abstract available.

Supplemental Content

Support Center